Literature DB >> 34698765

Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe.

Peter Libby1, Ziad Mallat2, Cornelia Weyand3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34698765      PMCID： PMC8783384          DOI： 10.1093/cvr/cvab332

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   13.081


× No keyword cloud information.
  10 in total

Review 1.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

2.  The heart of immunology: immune mechanisms in cardiovascular medicine.

Authors:  Göran K Hansson
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 3.  Inflammation during the life cycle of the atherosclerotic plaque.

Authors:  Peter Libby
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 4.  Cardiovascular comorbidities, inflammation, and cerebral small vessel disease.

Authors:  Lowri E Evans; Jade L Taylor; Craig J Smith; Harry A T Pritchard; Adam S Greenstein; Stuart M Allan
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 5.  Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies.

Authors:  Florentina Porsch; Ziad Mallat; Christoph J Binder
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 6.  Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.

Authors:  Gabrielle Fredman; Katherine C MacNamara
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 7.  Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.

Authors:  Eleanor C Murray; Ryszard Nosalski; Neil MacRitchie; Maciej Tomaszewski; Pasquale Maffia; David G Harrison; Tomasz J Guzik
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 8.  Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq.

Authors:  Jenifer Vallejo; Clément Cochain; Alma Zernecke; Klaus Ley
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 9.  Cardiac allograft vasculopathy: current review and future research directions.

Authors:  Jordan S Pober; Sharon Chih; Jon Kobashigawa; Joren C Madsen; George Tellides
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

Review 10.  Cardiovascular consequences of viral infections: from COVID to other viral diseases.

Authors:  Heinz-Peter Schultheiss; Christian Baumeier; Heiko Pietsch; C-Thomas Bock; Wolfgang Poller; Felicitas Escher
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787
  10 in total
  3 in total

1.  ESC CVD Prevention Guidelines 2021: improvements, controversies, and opportunities.

Authors:  Charalambos Antoniades; Henry W West
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 13.081

Review 2.  Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.

Authors:  Katarina Andelova; Barbara Szeiffova Bacova; Matus Sykora; Peter Hlivak; Miroslav Barancik; Narcis Tribulova
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

Review 3.  Endothelial Cells as a Key Cell Type for Innate Immunity: A Focused Review on RIG-I Signaling Pathway.

Authors:  Suowen Xu; Tengchuan Jin; Jianping Weng
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.